je.st
news
Inogen Rating Increased to Hold at Zacks
2015-11-15 04:55:28| Biotech - Topix.net
According to Zacks, "Inogen's unique direct-to-customer business model, innovative product suite and growing patient base are key growth catalysts in our view. Based on these the company raised its full-year 2015 revenue outlook and provided a strong full-year 2016 guidance.
Tags: rating
hold
increased
zacks
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||